Madrigal Pharmaceuticals Inc banner

Madrigal Pharmaceuticals Inc
LSE:0JXI

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
LSE:0JXI
Watchlist
Price: 497.265 USD -3.81%
Market Cap: $16.9B

Wall St Price Targets

0JXI Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast 0JXI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0JXI is 679.656 USD with a low forecast of 536.596 USD and a high forecast of 1 016.568 USD.

Lowest Forecast
Price Target
536.596 USD
8% Upside
Average Forecast
Price Target
679.656 USD
37% Upside
Highest Forecast
Price Target
1 016.568 USD
104% Upside
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
TELA
TELA Bio Inc
137% Upside
NCSM
NCS Multistage Holdings Inc
67% Upside
SANA
Sana Biotechnology Inc
146% Upside

Revenue
Forecast

102% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
102% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 26%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0JXI's stock price target?
Price Target
679.656 USD

According to Wall Street analysts, the average 1-year price target for 0JXI is 679.656 USD with a low forecast of 536.596 USD and a high forecast of 1 016.568 USD.

What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%

Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 26%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett